Barclays Reiterates Overweight Rating on Replimune Group (REPL), PT $17, 'We see this as a clear positive for Iovance's Amtagvi'

Go back to Barclays Reiterates Overweight Rating on Replimune Group (REPL), PT $17, 'We see this as a clear positive for Iovance's Amtagvi'
(NASDAQ: IOVA) Delayed: 6.98 +0.46 (7.06%)
Previous Close $6.52    52 Week High
Open $6.52    52 Week Low
Day High $7.00    P/E N/A 
Day Low $6.36    EPS
Volume 17,484,122       

Rider Explorations, Inc. (NASDAQ: REPL) Delayed: 14.97 -0.22 (1.45%)
Previous Close $15.19    52 Week High $1.45 
Open $15.19    52 Week Low $0.50 
Day High $15.39    P/E N/A 
Day Low $14.69    EPS $0.00 
Volume 2,398,383